ArticleCancers2026

Clinical and LAT1 Biomarker Correlates of Clinical Benefit from Nanvuranlat (JPH203) in Advanced Biliary Tract Cancer: A Post Hoc Analysis.

Eric K Rowinsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.